The immunoprecipitation market is projected to reach USD 750 million by 2024, at a CAGR of 5.0%. The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian